Burak Ezer | Immunology and Microbiology | Best Researcher Award

Dr. Burak Ezer | Immunology and Microbiology | Best Researcher Award

Medical Doctor | Beyhekim Training and Research Hospital | Turkey

Dr. Burak Ezer is a dedicated medical microbiologist whose work spans clinical microbiology, infectious diseases, and rare pathogen case studies. He has made significant contributions to the understanding of fungal and bacterial infections, chronic hepatitis, and viral seroprevalence, publishing extensively in both national and international peer-reviewed journals. His research emphasizes the clinical and diagnostic aspects of emerging pathogens, antimicrobial resistance, and serological markers, often employing advanced molecular and automated techniques. Dr. Ezer has demonstrated strong academic leadership through his role as corresponding author on numerous publications, participation in international and national conferences, and editorial and peer-review responsibilities for indexed journals. He has also contributed to book chapters, further consolidating his expertise in hepatitis and herpesvirus research. His collaborative efforts with multiple co-authors reflect a broad network and commitment to advancing medical science. Dr. Ezer’s measurable research impact is documented through Scopus, showing 9 publications, 1 citation, and an h-index of 1.

Profiles: Scopus | ORCID

Featured Publications

1. Ezer, B., Taşkın, Z., Kaba, K., Uğraklı, S., & Doğan, M. (2025). Comparison of automated systems using liquid microdilution for the determination of colistin resistance in Klebsiella pneumoniae strains. Turkish Bulletin of Hygiene and Experimental Biology.

2. Ezer, B., Esen, H. S., Ugrakli, S., Iyisoy, M. S., & Ozdemir, M. (2025, October 8). Association between serum HBV DNA levels and CCL-20, CD8a, CXCL-16, and GDF-15 in patients with chronic hepatitis B. Viruses.

3. Ezer, B., Ceylan, A., Arazi-Kan, S. N., Uğraklı, S., Bulut, R., & Demircioğlu, S. (2025, September 29). Fungemia caused by Fusarium proliferatum species complex in a patient with acute myeloid leukemia: A rare case report. Klimik Journal.

4. Ezer, B., Uğraklı, S., & Kasapoğlu, E. (2025, September 25). Kandidemi vakalarında hematolojik parametrelerin Albicans ve non-Albicans Candida türleri ile ilişkisi. Flora: The Journal of Infectious Diseases and Clinical Microbiology.

5. Ezer, B., Çiftci, H. S., Uğraklı, S., Bulut, R., & Gök, F. (2025, August 29). Candida auris fungemia confirmed by Sanger sequencing method: A rare case report. Genel Tıp Dergisi.

Bartholomew Saanu Adeleke | Immunology and Microbiology | Best Researcher Award

Dr. Bartholomew Saanu Adeleke | Immunology and Microbiology | Best Researcher Award

Lecturer and Researcher | Olusegun Agagu University of Science and Technology | Nigeria

Dr. Bartholomew Saanu Adeleke is a dedicated lecturer and researcher at Olusegun Agagu University of Science and Technology, Nigeria, with expertise in microbial biotechnology, soil-plant-microbe interactions, and next-generation sequencing. His academic journey includes a B.Sc. in Microbiology, M.Tech. in Food Microbiology, and Ph.D. in Science with Biology, earned from leading universities in Nigeria and South Africa. An early-career scientist with remarkable global recognition, he has consistently contributed to advancing knowledge in microbiology through high-quality publications and impactful collaborations across Africa, North America, Europe, and Asia. His work has been instrumental in demonstrating the potential of plant-associated microbiomes as sustainable alternatives to agrochemicals, offering vital solutions for food security and environmental sustainability. He also serves as an editor, reviewer, and member of professional bodies, enhancing the scientific community’s growth. His measurable research impact on Scopus includes 1,746 citations, 38 documents, and an h-index of 20.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1. B. S. A. O. O. Babalola, “Oilseed crop sunflower (Helianthus annuus) as a source of food: Nutritional and health benefits,” Food Science & Nutrition, vol. 8, pp. 4666–4684, 2020.

2. M. S. Ayilara, B. S. Adeleke, S. A. Akinola, C. A. Fayose, U. T. Adeyemi, et al., “Biopesticides as a promising alternative to synthetic pesticides: A case for microbial pesticides, phytopesticides, and nanobiopesticides,” Frontiers in Microbiology, vol. 14, p. 1040901, 2023.

3. B. S. Adeleke and O. O. Babalola, “Pharmacological potential of fungal endophytes associated with medicinal plants: A review,” Journal of Fungi, vol. 7, no. 2, p. 147, 2021.

4. B. S. Adeleke, M. S. Ayilara, S. A. Akinola, and O. O. Babalola, “Biocontrol mechanisms of endophytic fungi,” Egyptian Journal of Biological Pest Control, vol. 32, no. 1, p. 46, 2022.

5. B. S. Adeleke, O. O. Babalola, and B. R. Glick, “Plant growth-promoting root-colonizing bacterial endophytes,” Rhizosphere, vol. 20, p. 100433, 2021.

Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

Dr. Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

PhD Student at University of Medicine and Pharmacy of Craiova, Romania

Mohamed-Zakaria Assani is a dedicated and academically accomplished medical professional from Craiova, Romania. A graduate of the University of Medicine and Pharmacy of Craiova with a Doctor of Medicine degree, he is currently pursuing a PhD in Immunology, focusing on the implications of inflammation and atherosclerosis in chronic kidney disease. His academic excellence is reflected in his high GPAs and his master’s dissertation on population exposure to ionizing radiation. Mohamed-Zakaria has demonstrated leadership and community engagement through roles such as Project Coordinator for ONCOHELP and active volunteer work within student medical societies. He has participated in numerous congresses and clinical workshops, enhancing his practical and theoretical knowledge. Proficient in English and skilled in digital tools, he is well-equipped for research communication and collaboration. With a strong foundation in clinical research and a growing academic profile, he stands out as a promising early-career researcher committed to advancing medical science.

Professional Profile

ORCID Profile

Education

Mohamed-Zakaria Assani has an impressive academic background rooted in medical sciences. He graduated with a Doctor of Medicine (MD) degree from the University of Medicine and Pharmacy of Craiova, achieving an outstanding overall GPA of 9.69 and a dissertation exam GPA of 9.92. His academic excellence dates back to high school, where he earned a Baccalaureate GPA of 9.50 from the National College Frații Buzești in Craiova. Currently, he is pursuing a PhD in Immunology at the same university, where his research explores the interplay between inflammation, atherosclerosis, and chronic kidney disease—an area of critical importance in modern healthcare. His educational journey demonstrates consistent high performance, intellectual curiosity, and a solid foundation in both theoretical and practical aspects of medicine. He has also earned English language certifications (C1 level), further supporting his ability to engage with international research communities and access global academic resources effectively.

Professional Experience

Mohamed-Zakaria Assani has gained practical medical and leadership experience through a series of impactful roles. Currently, he serves as a resident in Laboratory Medicine at Filantropia Clinical Hospital and the Clinical Hospital of Neuropsychiatry in Craiova. These roles have enabled him to develop core diagnostic and analytical skills essential for laboratory-based and clinical research. Earlier in his academic journey, he demonstrated initiative and community engagement as a project coordinator for ONCOHELP within SSM Craiova and as a volunteer for various student-led projects, including TRANSMED and university-wide events such as the Freshman Ball. His participation in medical workshops and congresses—like the Annual Congress of Surgery for Students and CIMSC—further underscores his dedication to continuous professional development. These experiences have not only broadened his clinical perspective but also allowed him to build strong interpersonal and organizational skills, both crucial for team-based medical research and healthcare practice.

Research Interest

Mohamed-Zakaria Assani’s research interests lie at the intersection of immunology, cardiovascular pathology, and nephrology, focusing specifically on how inflammation and atherosclerosis contribute to chronic kidney disease (CKD). This multidisciplinary approach highlights his commitment to understanding complex disease mechanisms and improving patient outcomes through evidence-based research. His PhD work delves into the cellular and molecular pathways that drive disease progression in CKD, a pressing global health challenge. Additionally, his master’s dissertation explored population exposure to ionizing radiation from high-performance radiological investigations, demonstrating his early concern for public health and medical safety. Mohamed-Zakaria is driven by a desire to bridge laboratory findings with clinical applications, and his work holds the potential to inform diagnostic tools, therapeutic strategies, and preventive measures. His research aims not only to contribute new knowledge to the scientific community but also to enhance clinical practice, particularly in the management of chronic and systemic diseases.

Award and Honor

Although specific formal awards are not listed, Mohamed-Zakaria Assani’s academic record and extracurricular achievements position him as a strong candidate for recognition in research and leadership. Graduating with distinction from both high school and medical school, and earning high scores on his dissertation, he has consistently demonstrated academic excellence. His selection as a Project Coordinator within SSM Craiova for the ONCOHELP initiative, along with his active participation in prestigious student congresses such as CIMSC and the Annual Congress of Surgery, reflects peer and institutional acknowledgment of his capabilities. He also holds English proficiency certifications (Cambridge C1), further validating his readiness for international academic participation. His combination of scholarly commitment, volunteer service, and leadership roles speaks to a well-rounded and motivated individual deserving of early-career honors, such as young researcher awards or medical innovation fellowships. His profile illustrates promise and preparedness for future accolades in the field of medical research.

Conclusion

In conclusion, Mohamed-Zakaria Assani is a highly motivated and capable early-career medical researcher with a commendable blend of academic achievement, clinical experience, and leadership involvement. His educational accomplishments and current doctoral work in immunology place him at the forefront of critical research on chronic kidney disease. He has proactively contributed to both academic and volunteer communities, showing a strong sense of responsibility and dedication to healthcare. While he would benefit from expanding his research portfolio through publications and international collaborations, his foundational strengths are undeniable. With a clear focus on impactful, multidisciplinary research and a history of academic excellence, he is exceptionally well-positioned to contribute to the future of medical science. He is a promising candidate for research awards and a strong example of emerging talent in laboratory and clinical medicine. His continued progress will no doubt lead to significant contributions in the medical and scientific fields.

Publications Top Notes

1. Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients

  • Authors: Roxana-Viorela Ahrițculesei, Lidia Boldeanu, Daniel Cosmin Caragea, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Anca Marilena Ungureanu, Constantin Cristian Văduva, Anda Lorena Dijmărescu, Alin Iulian Silviu Popescu, et al.

  • Year: 2025

  • Citation: Ahrițculesei, R.-V., Boldeanu, L., Caragea, D. C., Vladu, M., Clenciu, D., Mitrea, A., Ungureanu, A. M., Văduva, C. C., Dijmărescu, A. L., Popescu, A. I. S., et al. (2025). Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients. International Journal of Molecular Sciences, 26(8), 3661. https://doi.org/10.3390/ijms26083661

2. Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy

  • Authors: Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Constantin Cristian Văduva, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Roxana-Viorela Ahrițculesei, Alexandra-Ștefania Stroe-Ionescu, Alexandru-Dan Assani, et al.

  • Year: 2025

  • Citation: Assani, M.-Z., Novac, M. B., Dijmărescu, A. L., Văduva, C. C., Vladu, M., Clenciu, D., Mitrea, A., Ahrițculesei, R.-V., Stroe-Ionescu, A.-Ș., Assani, A.-D., et al. (2025). Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy. Nutrients, 17(8), 1339. https://doi.org/10.3390/nu17081339

3. Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania

  • Authors: I. Prejbeanu, M. Z. Assani, F. Niculescu, L. A. Prunariu, R. G. Prejbeanu

  • Year: 2024

  • Citation: Prejbeanu, I., Assani, M. Z., Niculescu, F., Prunariu, L. A., & Prejbeanu, R. G. (2024). Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania. European Journal of Public Health, 34(Supplement 1), ckae144.2140. https://doi.org/10.1093/eurpub/ckae144.2140

Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

Dr. Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

MD at Izmir City Hospital, Turkey

Dr. Tuba Yüce İnel is a dedicated physician and researcher specializing in internal medicine, immunology, and rheumatology. With extensive experience in clinical practice and academic research, she has contributed significantly to the study of autoimmune diseases, inflammatory conditions, and rheumatological disorders. Her research focuses on understanding disease mechanisms and improving treatment approaches for complex conditions such as systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. Dr. İnel has published multiple papers in high-impact international journals, providing valuable insights into disease management and patient outcomes. Actively involved in scientific collaborations, she has participated in various national research projects aimed at advancing rheumatological medicine. She has also been recognized for her contributions with prestigious awards, highlighting her expertise and commitment to medical science.

Professional Profile

Education

Dr. Tuba Yüce İnel began her medical education at Hacettepe University School of Medicine, where she earned her Bachelor’s degree in Medicine in 2012. She then pursued a specialization in internal medicine at Istanbul University Faculty of Medicine, completing her training in 2017 with a thesis on the side effects of immunosuppressive treatments in primary glomerular diseases. Her academic journey continued with a minor specialization in Immunology and Rheumatology at Dokuz Eylül University, where she completed her training in 2022. Through her education at leading Turkish medical institutions, Dr. İnel gained extensive clinical expertise and research experience, shaping her career in autoimmune and inflammatory diseases.

Professional Experience

Dr. İnel has held key positions as a Research Assistant at both Istanbul University (2012-2017) and Dokuz Eylül University (2018-present), where she has contributed to research and medical education. She has played a significant role in clinical studies related to autoimmune diseases, particularly focusing on systemic sclerosis and inflammatory pathways. Additionally, she has been actively involved in teaching and mentoring medical students and residents, sharing her expertise in rheumatology and immunology. Her professional journey includes participation in several government-funded scientific research projects, further solidifying her role as a leading researcher in rheumatology.

Research Interests

Dr. İnel’s research focuses on autoimmune diseases, inflammatory rheumatologic disorders, and immunology, with a particular emphasis on systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. She has explored the role of immune pathways, including the NEK7-NLRP3 inflammasome pathway, in disease progression and treatment response. Her studies on plasma arginine-citrulline levels in systemic sclerosis have contributed to understanding disease severity and malabsorption mechanisms. Additionally, her research on obesity’s impact on ankylosing spondylitis treatment has provided real-world data on therapeutic outcomes. She continues to investigate novel biomarkers and targeted treatments to improve patient care and enhance therapeutic strategies in rheumatology.

Awards and Honors

Dr. İnel’s outstanding research has earned her recognition and accolades within the medical community. In 2022, she won the First Prize for Oral Presentation in Spondyloarthritis, awarded by the Turkish Rheumatology Association, highlighting her excellence in presenting groundbreaking research. Her work has been published in internationally recognized journals, showcasing her significant contributions to rheumatology and immunology. She is also an active member of the Turkish Rheumatology Association, reflecting her commitment to advancing knowledge and collaboration in her field. Through her academic achievements, research excellence, and clinical expertise, Dr. İnel continues to establish herself as a leading figure in rheumatology research.

Conclusion

Dr. Tuba Yüce İnel is a strong candidate for the Best Researcher Award due to her academic achievements, impactful research in rheumatology, national recognition, and continuous contributions to scientific literature. If she enhances international collaborations, takes leadership roles in research projects, and secures external funding, her candidacy would become even more compelling.

Publications Top Noted

1. A Life-Threatening Manifestation of Granulomatosis with Polyangiitis: Subglottic Stenosis

  • Authors: Yüce-İnel, T., Uslu, S.
  • Year: 2024
  • Journal: Archives of Rheumatology
  • Citations: 0

2. Assessing Safety and Efficacy of TNFi Treatment in Late-Onset Ankylosing Spondylitis: A TURKBIO Registry Study

  • Authors: Uslu, S., Gülle, S., Sen, G., Akkoç, N., Onen, F., Yüce-İnel, T.
  • Year: 2024
  • Journal: Scientific Reports
  • Citations: 4